Here are three things to know.
- Fycompa is a once-daily tablet patients take before bed.
- The agency first approved Fyompa in 2012 as an adjunct therapy for partial-onset seizures. The drug can now be used as a sole treatment for the condition.
- The drug acts as an agonist to limit the overstimulation of neurons associated with seizures.
More articles on supply chain:
6 must-reads for supply chain leaders this week
Tip: Time back through supply chain workflow optimization
Intermountain adopts needle-free technology for blood draws
